The goal of this activity is for learners to be better able to assess the latest clinical trial data on the treatment of MM from the 2024 ASH Annual Meeting and confidently integrate these data into their clinical practice when appropriate.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/multiple-myeloma-key-highlights-ash-2024-2024a1000otf
- Start Date: 2025-01-13 06:00:00
- End Date: 2025-01-13 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: GlaxoSmithKline - Amount: 50000.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 85000.0 - Is Kind Support: False Source: Legend BioTech - Amount: 12500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest